Custom polyclonal antibody production: choosing the host and the immunogen, what a rabbit polyclonal antibody production schedule delivers, how polyclonal antibodies production differs when a chicken antibody is the right answer, what polyclonal antibodies cost you in finiteness, and the purification and validation that decide whether the serum is usable

Staging the project

1. Choose the host by phylogenetic distance and volume needed. The host must see the antigen as foreign, so a target conserved between your species and the host gives a poor response. Rabbits give a good response and a useful serum volume; larger hosts give far more serum for a reagent that will be used for years; mice give little and are usually a route to a monoclonal instead.
2. Design the immunogen, and conjugate it if it is small. A peptide under roughly ten kilodaltons will not raise a response alone and must be coupled to a carrier protein. Choose a peptide from an exposed, non-conserved region, and check it against the proteome so the serum does not recognise half the lysate.
3. Fix the schedule and the bleeds in the contract. A standard programme is a primary immunisation with boosts every two to three weeks and test bleeds through a seventy to ninety day cycle. Agree what happens if titre is low at the first test bleed, because that decision point is where projects either recover or drift.
4. Decide the purification before the serum arrives. Whole serum is cheapest and has the most background. Protein A or G gives total immunoglobulin. Antigen affinity purification gives the specific fraction and is what most applications actually need. The right answer depends on the application and it is much cheaper to specify than to add later.
5. Validate against a negative that should be negative. Preimmune serum from the same animal, and a sample lacking the target, are the two controls that separate a specific reagent from a hopeful one. Both belong in the deliverable rather than in a later experiment.

Checking the provider's animal welfare position

Ask for the facility's registration and assurance status, the institutional committee that approved the protocol, and the adjuvant and route used. These are straightforward questions for a reputable provider and the answers are documents, not assurances.

Where work will be published or used to support a submission, that documentation is likely to be requested later. Collecting it at the point of order costs nothing; reconstructing it afterwards is sometimes impossible.

Making a finite reagent last

Aliquot on arrival, record the volume, and titrate properly so the working dilution is the most dilute that works. A serum used at twice the necessary concentration lasts half as long for no benefit.

Keep a reserve of the original unpurified serum. If a purification goes wrong or an application needs a different fraction later, the reserve is the only thing that makes that recoverable.

What to do when the animal is exhausted

Plan the transition before the last aliquot. Options are a new animal with the same immunogen, which gives a different serum that has to be revalidated, or converting to a recombinant reagent by cloning the variable regions from B cells while the animal is available.

The recombinant route is the only one that makes the reagent permanent, and it has to be decided while the animal is alive. That timing is the single most common regret in polyclonal projects.

Common questions

How long does custom polyclonal antibody production take?

Typically seventy to ninety days from immunisation to a final bleed, plus purification. Peptide synthesis and carrier conjugation add a few weeks at the front, and a poor first response can add a whole boost cycle.

Why choose rabbit polyclonal antibody production?

Rabbits raise a strong response to most mammalian targets, give a usable serum volume, and there is a very wide range of anti-rabbit secondary reagents available. For most laboratory applications it is the default for good reasons.

Polyclonal or monoclonal?

Polyclonal for sensitivity, for denatured targets and for immunoprecipitation, and where a finite supply is acceptable. Monoclonal where the reagent must be identical for years, where specificity has to be exact, or where the assay will be validated once and run indefinitely.

Do I own the antigen and the serum?

Only if the contract says so. Ownership of the immunogen, the serum, any residual and the right to resell are separate points, and providers differ. Settle them before work starts.

Browse by service class

• Compare Gene synthesis on advertised prices